Global Uterine Fibroids Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024


  • Scope of the Report:

    The global Uterine Fibroids Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

    The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

    North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Uterine Fibroids Treatment.

    Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

    This report studies the Uterine Fibroids Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Uterine Fibroids Treatment market by product type and applications/end industries.


    Market Segment by Companies, this report covers

    LiNA Medical

    Merit Medical Systems

    Cooper Surgical

    Richard Wolf Medical Instruments

    Blue Endo

    Boston Scientific Corporation

    Richard Wolf GmbH

    Karl Storz

    Halt Medical, Inc.

    Olympus Corporation

    Halt Medical, Inc. 


    Market Segment by Regions, regional analysis covers

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Russia and Italy)

    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

    South America (Brazil, Argentina, Colombia)

    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)


    Market Segment by Type, covers

    Endometrial Ablation

    MRI Guided Procedures

    Hysterectomy

    Myomectomy

    Uterine Artery Embolization

    Radiofrequency Ablation

    Others


    Market Segment by Applications, can be divided into

    Hospitals

    Ambulatory Surgical Centers

    Others

     

  • Table of Contents

    1 Uterine Fibroids Treatment Market Overview

    1.1 Product Overview and Scope of Uterine Fibroids Treatment

    1.2 Classification of Uterine Fibroids Treatment by Types

    1.2.1 Global Uterine Fibroids Treatment Revenue Comparison by Types (2019-2024)

    1.2.2 Global Uterine Fibroids Treatment Revenue Market Share by Types in 2018

    1.2.3 Endometrial Ablation

    1.2.4 MRI Guided Procedures

    1.2.5 Hysterectomy

    1.2.6 Myomectomy

    1.2.7 Uterine Artery Embolization

    1.2.8 Radiofrequency Ablation

    1.2.9 Others

    1.3 Global Uterine Fibroids Treatment Market by Application

    1.3.1 Global Uterine Fibroids Treatment Market Size and Market Share Comparison by Applications (2014-2024)

    1.3.2 Hospitals

    1.3.3 Ambulatory Surgical Centers

    1.3.4 Others

    1.4 Global Uterine Fibroids Treatment Market by Regions

    1.4.1 Global Uterine Fibroids Treatment Market Size (Million USD) Comparison by Regions (2014-2024)

    1.4.1 North America (USA, Canada and Mexico) Uterine Fibroids Treatment Status and Prospect (2014-2024)

    1.4.2 Europe (Germany, France, UK, Russia and Italy) Uterine Fibroids Treatment Status and Prospect (2014-2024)

    1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Uterine Fibroids Treatment Status and Prospect (2014-2024)

    1.4.4 South America (Brazil, Argentina, Colombia) Uterine Fibroids Treatment Status and Prospect (2014-2024)

    1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Uterine Fibroids Treatment Status and Prospect (2014-2024)

    1.5 Global Market Size of Uterine Fibroids Treatment (2014-2024)

    2 Company Profiles

    2.1 LiNA Medical

    2.1.1 Business Overview

    2.1.2 Uterine Fibroids Treatment Type and Applications

    2.1.2.1 Product A

    2.1.2.2 Product B

    2.1.3 LiNA Medical Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.2 Merit Medical Systems

    2.2.1 Business Overview

    2.2.2 Uterine Fibroids Treatment Type and Applications

    2.2.2.1 Product A

    2.2.2.2 Product B

    2.2.3 Merit Medical Systems Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.3 Cooper Surgical

    2.3.1 Business Overview

    2.3.2 Uterine Fibroids Treatment Type and Applications

    2.3.2.1 Product A

    2.3.2.2 Product B

    2.3.3 Cooper Surgical Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.4 Richard Wolf Medical Instruments

    2.4.1 Business Overview

    2.4.2 Uterine Fibroids Treatment Type and Applications

    2.4.2.1 Product A

    2.4.2.2 Product B

    2.4.3 Richard Wolf Medical Instruments Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.5 Blue Endo

    2.5.1 Business Overview

    2.5.2 Uterine Fibroids Treatment Type and Applications

    2.5.2.1 Product A

    2.5.2.2 Product B

    2.5.3 Blue Endo Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.6 Boston Scientific Corporation

    2.6.1 Business Overview

    2.6.2 Uterine Fibroids Treatment Type and Applications

    2.6.2.1 Product A

    2.6.2.2 Product B

    2.6.3 Boston Scientific Corporation Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.7 Richard Wolf GmbH

    2.7.1 Business Overview

    2.7.2 Uterine Fibroids Treatment Type and Applications

    2.7.2.1 Product A

    2.7.2.2 Product B

    2.7.3 Richard Wolf GmbH Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.8 Karl Storz

    2.8.1 Business Overview

    2.8.2 Uterine Fibroids Treatment Type and Applications

    2.8.2.1 Product A

    2.8.2.2 Product B

    2.8.3 Karl Storz Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.9 Halt Medical, Inc.

    2.9.1 Business Overview

    2.9.2 Uterine Fibroids Treatment Type and Applications

    2.9.2.1 Product A

    2.9.2.2 Product B

    2.9.3 Halt Medical, Inc. Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.10 Olympus Corporation

    2.10.1 Business Overview

    2.10.2 Uterine Fibroids Treatment Type and Applications

    2.10.2.1 Product A

    2.10.2.2 Product B

    2.10.3 Olympus Corporation Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    2.11 Halt Medical, Inc. 

    2.11.1 Business Overview

    2.11.2 Uterine Fibroids Treatment Type and Applications

    2.11.2.1 Product A

    2.11.2.2 Product B

    2.11.3 Halt Medical, Inc.  Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Uterine Fibroids Treatment Market Competition, by Players

    3.1 Global Uterine Fibroids Treatment Revenue and Share by Players (2014-2019)

    3.2 Market Concentration Rate

    3.2.1 Top 5 Uterine Fibroids Treatment Players Market Share

    3.2.2 Top 10 Uterine Fibroids Treatment Players Market Share

    3.3 Market Competition Trend

    4 Global Uterine Fibroids Treatment Market Size by Regions

    4.1 Global Uterine Fibroids Treatment Revenue and Market Share by Regions

    4.2 North America Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    4.3 Europe Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    4.4 Asia-Pacific Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    4.5 South America Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    4.6 Middle East and Africa Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    5 North America Uterine Fibroids Treatment Revenue by Countries

    5.1 North America Uterine Fibroids Treatment Revenue by Countries (2014-2019)

    5.2 USA Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    5.3 Canada Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    5.4 Mexico Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    6 Europe Uterine Fibroids Treatment Revenue by Countries

    6.1 Europe Uterine Fibroids Treatment Revenue by Countries (2014-2019)

    6.2 Germany Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    6.3 UK Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    6.4 France Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    6.5 Russia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    6.6 Italy Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Uterine Fibroids Treatment Revenue by Countries

    7.1 Asia-Pacific Uterine Fibroids Treatment Revenue by Countries (2014-2019)

    7.2 China Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    7.3 Japan Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    7.4 Korea Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    7.5 India Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    7.6 Southeast Asia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    8 South America Uterine Fibroids Treatment Revenue by Countries

    8.1 South America Uterine Fibroids Treatment Revenue by Countries (2014-2019)

    8.2 Brazil Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    8.3 Argentina Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    8.4 Colombia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Uterine Fibroids Treatment by Countries

    9.1 Middle East and Africa Uterine Fibroids Treatment Revenue by Countries (2014-2019)

    9.2 Saudi Arabia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    9.3 UAE Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    9.4 Egypt Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    9.5 Nigeria Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    9.6 South Africa Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)

    10 Global Uterine Fibroids Treatment Market Segment by Type

    10.1 Global Uterine Fibroids Treatment Revenue and Market Share by Type (2014-2019)

    10.2 Global Uterine Fibroids Treatment Market Forecast by Type (2019-2024)

    10.3 Endometrial Ablation Revenue Growth Rate (2014-2024)

    10.4 MRI Guided Procedures Revenue Growth Rate (2014-2024)

    10.5 Hysterectomy Revenue Growth Rate (2014-2024)

    10.6 Myomectomy Revenue Growth Rate (2014-2024)

    10.7 Uterine Artery Embolization Revenue Growth Rate (2014-2024)

    10.8 Radiofrequency Ablation Revenue Growth Rate (2014-2024)

    10.9 Others Revenue Growth Rate (2014-2024)

    11 Global Uterine Fibroids Treatment Market Segment by Application

    11.1 Global Uterine Fibroids Treatment Revenue Market Share by Application (2014-2019)

    11.2 Uterine Fibroids Treatment Market Forecast by Application (2019-2024)

    11.3 Hospitals Revenue Growth (2014-2019)

    11.4 Ambulatory Surgical Centers Revenue Growth (2014-2019)

    11.5 Others Revenue Growth (2014-2019)

    12 Global Uterine Fibroids Treatment Market Size Forecast (2019-2024)

    12.1 Global Uterine Fibroids Treatment Market Size Forecast (2019-2024)

    12.2 Global Uterine Fibroids Treatment Market Forecast by Regions (2019-2024)

    12.3 North America Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)

    12.4 Europe Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)

    12.5 Asia-Pacific Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)

    12.6 South America Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)

    12.7 Middle East and Africa Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

    14 Appendix

    14.1 Methodology

    14.2 Data Source

     

This is a single user license, allowing one specific user access to the product.

This is a 1-10 user licence, allowing up to ten users have access to the product.

This is a site license, allowing all users within a given geographical location of your organisation access to the product.

Need Assistance ?

Our Clients